Results 131 to 140 of about 1,042 (183)
Some of the next articles are maybe not open access.

Thoracoscopic talc poudrage in pneumothorax

1.4 Interventional Pulmonology, 2015
Introduction: Medical thoracoscopy (MT) has been demonstrated to be safe and effective when treating pneumothorax cases by talc poudrage. Aims: We sought to characterize the population of patients with pneumothorax that underwent talc poudrage by MT and its late recurrence rate.
Patrícia Dionísio   +5 more
openaire   +1 more source

Systemic Inflammatory Reaction After Thoracoscopic Talc Poudrage

Chest, 2006
Recent studies have reported fever as a side effect of talc poudrage during thoracoscopic pleurodesis. However, thoracoscopy itself is likely to induce systemic inflammatory reaction, as it is an interventional procedure. The aim of the study was to investigate whether systemic inflammatory response is due to talc poudrage or to thoracoscopy.We ...
Marios E, Froudarakis   +2 more
openaire   +2 more sources

TREATMENT OF MALIGNANT PLEURAL EFFUSIONS BY TALC POUDRAGE

Journal of the American Medical Association, 1960
The operation of talc poudrage here described is designed to stop persistent pleural effusions in cases of incurable cancer. The incision permits exploration of the affected hemithorax and can be extended if the lesion is found to be resectable.
G J, HAUPT   +3 more
openaire   +2 more sources

Thoracoscopy and talc poudrage for pneumothoraces and effusions

The Annals of Thoracic Surgery, 1990
The indications, technique, and results of thoracoscopic talc poudrage in the two clinical settings of pneumothorax and recurrent pleural effusion in chronically ill patients are reported. Forty patients underwent this treatment between May 1982 and September 1989. The patients ranged in age from 10 months to 78 years.
T M, Daniel, C G, Tribble, B M, Rodgers
openaire   +2 more sources

Thoracoscopic talc Poudrage pleurodesis for malignant effusions

1.4 Interventional Pulmonology, 2015
Introduction: Malignant pleural effusion is a common medical problem in patients with primary lung cncer or metastatic.It defines an advanced form of the disease and is an index of poor prognosis.Medical thoracoscopy(MTh) is a technique which primary used for the diagnosis but it also allows talc poudrage for controlling recurrent symptomatic ...
Xanthi Tsiafaki   +4 more
openaire   +1 more source

Thoracoscopic Talc Poudrage Pleurodesis for Chronic Recurrent Pleural Effusions

Annals of Internal Medicine, 1991
To assess the effectiveness of thoracoscopic talc poudrage for the treatment of chronic pleural effusions.Prospective evaluation.Kaiser-Permanente Hospital.Forty-seven consecutive patients with recalcitrant pleural effusions, referred for thoracoscopy.Patients received general or local anesthesia; 42 had a 7-mm rigid thoracoscopic examination followed ...
Y, Aelony, R, King, C, Boutin
openaire   +2 more sources

Thoracoscopy and Talc Poudrage in the Management of Hepatic Hydrothorax

Chest, 2000
To determine indications, limitations, morbidity and mortality of surgical thoracoscopy for management of hepatic hydrothorax, a rare, but often recurrent, complication in cirrhotic patients.From May 1985 through May 1999, 10 men and 8 women, with a mean age of 57.6 years (range, 26 to 76 years), underwent 21 therapeutic thoracoscopies to achieve ...
J R, Milanez de Campos   +6 more
openaire   +2 more sources

Prolonged survival after talc poudrage for malignant pleural mesothelioma: Case series

Respirology, 2005
Objective:  Malignant pleural mesothelioma is a fatal disease with a mean life expectancy of 6–12 months. Since 1982, we have performed thoracoscopic talc poudrage (TTP) as a primary therapy in mesothelioma patients presenting with pleural effusion.
Yossef, Aelony, Janis F, Yao
openaire   +2 more sources

Talc Poudrage for Treatment of Pleural Effusion in Selected Patients

AORN Journal, 1995
ABSTRACTRecurring pleural effusions are a significant cause of patient morbidity. Treatment goals are to relieve distressing symptoms (eg, dyspnea, pain) caused by the effusion, to prevent further extracellular fluid accumulation in the pleural space, and to restore the patient to a functional pulmonary status.
openaire   +2 more sources

Thoracoscopy talc poudrage : a 15-year experience.

Chest, 2001
To review our experience with thoracoscopy and talc poudrage during the previous 15 years with regards to efficacy, side effects, morbidity, and mortality.Six hundred fourteen consecutive patients (58.6% female; mean age, 54.5 years) underwent thoracoscopy with talc poudrage from August 1983 to May 1999.
J R, de Campos   +6 more
openaire   +1 more source

Home - About - Disclaimer - Privacy